Virologic Outcomes at Week 48 (by FDA snapshot)
{"Image DocumentName": "Virologic Outcomes at Week 48 (by FDA snapshot)", "Image ImageDescription": "1% (3 patients) had virologic failure. 2 patients showed resistance. 1 patient with HIV-1 RNA <50 copies/mL on E/C/F/TAF prior to switching to new regimen. 1 patient with HIV-1 RNA <400 copies/mL on E/C/F/TAF; NRTI and PI resistance identical to pre-study historical genotype. 1 patient took additional antiretrovirals (rilpivirine/emtricitabine/TDF) through Day 67 (protocol violation) Now on E/C/F/TAF alone with HIV-1 RNA <50 copies/mL through Week 48. Pozniak, et al. CROI, 2015, #795.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}